SCHEMBL5764801

SCHEMBL5764801

CCc1cc2c(OCC(=O)OC)ncnc2n1Cc1cccc(C(F)(F)F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 3/20 0.42
RPS6KB1 P23443 3/20 0.42
ABHD6 Q9BV23 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
PTGER3 P43115 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPK1 P28482 2/20 0.38
CDK2 P24941 1/20 0.38
MAPK8 P45983 1/20 0.38
CSNK1A1 P48729 1/20 0.38
CSNK1D P48730 1/20 0.38
CDK7 P50613 1/20 0.38
CCNH P51946 1/20 0.38
MNAT1 P51948 1/20 0.38
MAPT P10636 1/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
TSHR P16473 1/20 0.38
SCN9A Q15858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5762337 0.88 MAPT (0.41) AURKARPS6KB1SMN1; SMN2ALDH1A1MAPK1
SCHEMBL5765082 0.86 PKM (0.43) SMN1; SMN2ALDH1A1MAPTLMNATSHR
SCHEMBL5765093 0.86 PTGDR2 (0.42) SMN1; SMN2KDM4EALDH1A1MAPTHTT
SCHEMBL5764673 0.85 LMNA (0.37) ABHD6SMN1; SMN2PTGER3MAPK1MAPT
SCHEMBL5764869 0.79 PLA2G2A (0.47) AURKARPS6KB1RIPK1
SCHEMBL5762171 0.76 PLA2G1B (0.42) SMN1; SMN2KDM4EALDH1A1MAPT
SCHEMBL5764178 0.73 MAPT (0.40) KDM4EALDH1A1MAPK1MAPTLMNA
SCHEMBL5763931 0.70 HSP90AA1 (0.40) SMN1; SMN2PTGER3KDM4EALDH1A1PPARG
SCHEMBL5763265 0.70 PLA2G2A (0.52)
SCHEMBL5763509 0.69 PLA2G2A (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1091738-B1 BICYCLIC sPLA 2 INHIBITORS LILLY CO ELI (US) 2006-12-06 EP disclosed
US-6384041-B1 ANTIINFLAMMATORY AGENT, TREATMENT OF SHOCK AND ENZYME INHIBITORS ELI LILLY AND COMPANY 2002-05-07 US disclosed